GTCR PARTNERS XI/B LP — SEC Form 4 filings

SEC reporting owner CIK 1827959. 1 Form 4 filing on record with FilingPulse; latest filed 2024-05-30.

Transaction summary — filings shown

Covers all 1 filing on record, filed 2024-05-30 to 2024-05-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)Director, 10% owner11 leg · 9,940,974 sh · $97,570,6603

Form 4 filings — GTCR PARTNERS XI/B LP

FiledFormIssuerReported transactionsSource
2024-05-304MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
jointly with GTCR INVESTMENT XI LLC, MARAVAI LIFE SCIENCES HOLDINGS, LLC, MARAVAI LIFE SCIENCES HOLDINGS 2, LLC, GTCR FUND XI/B LP, GTCR FUND XI/C LP, GTCR CO-INVEST XI LP, GTCR PARTNERS XI/A&C LP
Disposition to issuer (D): 8,409,946 · Conversion (C): 8,409,946 · Sale (S): 9,940,974 @ $9.81 · Conversion (C): 8,409,946 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1827959 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →